Christoffer Nilmén

Associate, Stockholm

Biography

Overview

Christoffer Nilmén is an associate in our Capital Markets practice in Stockholm and joined White & Case in 2019.

Prior to joining White & Case, Christoffer studied at Stockholm University and at University of Auckland. He commenced his career at the Firm as a junior trainee.

Education
LLM
Juris kandidat
Stockholm University
Studies in Commercial Law
University of Auckland
Languages
Swedish
English

Experience

Representation of Carnegie Investment Bank and Danske Bank, Danmark, Sverige Filial, as joint global coordinators, and ABG Sundal Collier, Jefferies International and Nordea, filial i Sverige, as joint bookrunners, on the SEK 9.838 billion initial public offering and Nasdaq Stockholm listing of Cint Group, a global software leader in digital insights gathering.

Representation of Carnegie Investment Bank AB, J.P. Morgan Securities plc and Citigroup Global Markets Limited, as joint global coordinators, and ABG Sundal Collier AB, Joh. Berenberg, Gossler & Co. KG, DNB Bank ASA, Sweden branch and Skandinaviska Enskilda Banken AB (publ), as joint bookrunners, on the SEK 10.378 billion initial public offering and Nasdaq Stockholm listing of Nordnet, a digital bank for savings and investments.

Representation of ABG Sundal Collier and Svenska Handelsbanken, as managers, on the SEK 828 million initial public offering and Nasdaq Stockholm listing of Readly AB, a leading provider of digital magazines.

Representation of Svenska Handelsbanken, a Swedish major bank, on a landmark issuance of US$ 1 billion AT1 Contingent Convertibles in two tranches of US$ 500 million each at interest rates of 4.375% and 4.75% respectively. The Notes are perpetual instruments however, the Issuer has the option to redeem after 6.5 years (March 2027) and 10.5 years (March 2031) and then subsequently every fifth year. The issuance is in the form of debt instruments with automatic conversion to class A-shares, if the Issuer's common equity tier 1 ratio falls below a certain level.

Representation of Morgan Stanley & Co. International plc, Van Lanschot Kempen Wealth Management N.V. and Zonda Partners AB on the directed share issue of approximately SEK 1,112 million (US$ 121 million) by Hansa Biopharma.

Representation of Jefferies International Limited, Carnegie Investment Bank AB (publ), DNB Markets, a part of DNB Bank ASA, Cowen and Company, LLC and Van Lanschot Kempen Wealth Management N.V., all financial services providers, on the directed share issue of approximately SEK 1,414 million (USD 144 million) by Oncopeptides, a pharmaceutical company developing drugs for the treatment of cancer.

Representation of Carnegie Investment Bank, a financial services group, as sole global coordinator and joint bookrunner and Swedbank, a Nordic-Baltic banking group, as joint bookrunner in connection with the EUR 64 million IPO and Nasdaq Helsinki listing of Optomed, a Finnish health care technology company.

Representation of DNB, Danske Bank and Nordea, all financial services group, as managers in connection with the SEK 1,215 million rights issue in Ambea AB, a Nasdaq Stockholm listed residential care company.

Representation of Carnegie and Nordea, both financial services groups, in connection with the SEK 4.2 billion IPO and Nasdaq Stockholm listing of Karnov Group, a leading provider of mission critical information in the areas of legal, tax and accounting, and environmental, health and safety.

Representation of Gaming Innovation Group, a cloud-based online gaming platform incorporated in Delaware and listed on the Oslo Stock Exchange, in connection with the dual listing of the company's shares on Nasdaq Stockholm.

Representation of ÅF, an engineering and design company within the fields of energy, industry and infrastructure, on the recommended cash Tender Offer for all shares in Pöyry, an international consulting and engineering company. ÅF and Pöyry have signed an agreement to combine the two companies to form a leading European engineering and consulting company.

Representation of EQT, a leading global investment firm, on the public cash offer to the shareholders of Karo Pharma, a company that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products.

Representation of European Entertainment Intressenter BidCo AB (EE Intressenter), a privately held investment company, on the SEK 9.2 billion (SEK 87 per share) public cash offer to the shareholders in Cherry AB, one of Scandinavia’s oldest gaming companies, to acquire all Cherry shares.